Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts.
A I
AI
Sánchez-Moya
E
E
Daudén
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D055985:Latent Tuberculosis / Q000175:diagnosis*; D008403:Mass Screening / Q000379:methods*; D011565:Psoriasis / Q000188:drug therapy*; D014374:Tuberculin Test / Q000379:methods* / Q000592:standards; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha